Stock Worth Mentioning Today: Is Selling Bovie Medical Corporation Here a Winning Strategy?

Stock Worth Mentioning Today: Is Selling Bovie Medical Corporation Here a Winning Strategy?

The stock of Bovie Medical Corporation (NYSEMKT:BVX) is a huge mover today! About 1.06M shares traded hands or 516.38% up from the average. Bovie Medical Corporation (NYSEMKT:BVX) has risen 171.51% since April 8, 2016 and is uptrending. It has outperformed by 165.86% the S&P500.
The move comes after 8 months negative chart setup for the $109.07 million company. It was reported on Nov, 10 by We have $3.57 PT which if reached, will make NYSEMKT:BVX worth $12.00 million less.

According to Zacks Investment Research, “Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devices and advanced coating technologies.”

Insitutional Activity: The institutional sentiment decreased to 0.54 in Q2 2016. Its down 0.60, from 1.14 in 2016Q1. The ratio worsened, as 7 funds sold all Bovie Medical Corporation shares owned while 6 reduced positions. 2 funds bought stakes while 5 increased positions. They now own 4.70 million shares or 6.35% less from 5.02 million shares in 2016Q1.
Moreover, Morgan Stanley has 0% invested in Bovie Medical Corporation (NYSEMKT:BVX) for 6,700 shares. Perkins Cap Management Inc accumulated 355,740 shares or 0.67% of the stock. Salem Invest Counselors Incorporated last reported 0.01% of its portfolio in the stock. California Employees Retirement Systems, a California-based fund reported 28,177 shares. Renaissance Techs Ltd Liability accumulated 149,600 shares or 0% of the stock. Blackrock Advsr Ltd last reported 7,643 shares in the company. Vanguard Grp Inc accumulated 540,757 shares or 0% of the stock. Blackrock Fund Advsr has 0% invested in the company for 72,051 shares. Kennedy has invested 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX). National Bank Of America De last reported 102 shares in the company. Creative Planning reported 1,475 shares or 0% of all its holdings. Northern last reported 54,945 shares in the company. Oppenheimer Inc accumulated 10,400 shares or 0% of the stock. Blackrock Invest reported 4,801 shares or 0% of all its holdings. Wasatch Advsrs, a Utah-based fund reported 340,000 shares.

Insider Transactions: Since August 17, 2016, the stock had 1 insider buy, and 0 insider sales for $299,475 net activity. 90,750 shares were bought by McCarthy John J. III, worth $299,475 on Wednesday, August 17.

More notable recent Bovie Medical Corporation (NYSEMKT:BVX) news were published by: which released: “Bovie Medical Prices Public Offerings of Common Stock” on November 10, 2016, also with their article: “Bovie Medical Corp. NYSE MKT: BVX” published on November 10, 2010, published: “Bovie Medical Corporation Announces Third Quarter 2016 Earnings Call” on October 11, 2016. More interesting news about Bovie Medical Corporation (NYSEMKT:BVX) were released by: and their article: “Bovie Medical Corporation Announces CFO Transition” published on June 15, 2015 as well as‘s news article titled: “Bovie Medical Corporation’s (BVX) CEO Rob Gershon on Q3 2016 Results …” with publication date: October 27, 2016.

BVX Company Profile

Bovie Medical Corporation (Bovie), incorporated on December 3, 1982, is an energy medical device company. The Firm is also engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. The Firm operates through three divisions: Core, OEM and J-Plasma. The Firm is engaged in developing, manufacturing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor’s offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit (ESU), a handpiece and a supply of helium gas. The Company’s medical devices are marketed through its own brands, including Bovie, Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. The Firm offers its products in three categories: electrosurgery, cauteries and other products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment